Imperial College London
Clinical trials sponsored by Imperial College London, explained in plain language.
-
Promising cancer drug trial halted after just one patient
Disease control TerminatedThis study aimed to see if giving Lutathera (a radioactive drug) after surgery to remove liver metastases from neuroendocrine tumors could help keep the cancer from coming back. It planned to compare Lutathera plus best supportive care against best supportive care alone in about …
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Radioactive beads aim to shrink untreatable liver tumors
Disease control TerminatedThis early trial tested the safety and effectiveness of radioactive beads (Holmium-166 microspheres) in 4 adults with liver cancer that could not be removed by surgery or transplant. Participants first received a small scout dose to check for proper placement, then a personalized…
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 26, 2026 19:18 UTC
-
New automated insulin system tested in tiny trial
Disease control TerminatedThis study tested a system that automatically adjusts insulin delivery using a continuous glucose monitor, a smartphone app, and an insulin pump. It aimed to see if the system could help adults with type 1 diabetes spend more time with their blood sugar in a healthy range. Only o…
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 26, 2026 12:39 UTC
-
Heart rhythm study seeks to predict ablation success
Knowledge-focused TerminatedThis study looked at a common heart rhythm problem called atrial fibrillation (AF). The goal was to find better ways to predict which patients would benefit from a procedure called ablation, which creates scar tissue in the heart to stop abnormal rhythms. Researchers planned to u…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC